Neuroblastoma - Pediatric
Back to Oncology/Cancer Clinical Trials Main PageCPMC Cancer Services
| Principal Investigator/Contact Information | Protocol Title | Patient Population | Recruitment Period |
| Principal Investigator: CPMC Oncologists Contact: Catherine Carr 415-600-1369 | Neuroblastoma Biology Studies. ANBL00B1 | Pediatric patients with Neuroblastoma | Open |
| Principal Investigator: CPMC Oncologists Contact: Catherine Carr 415-600-1369 | A Phase II Study of Irinotecan + Temozolomide in Children with Recurrent Neuroblastoma. ANBL0421 | Pediatric patients with recurrent Neuroblastoma | Open |
| Principal Investigator: CPMC Oncologists Contact: Catherine Carr 415-600-1369 | A Phase II study of hu14.18-IL2 (BB-IND-9728) in Children with Recurrent or Refractory Neuroblastoma. ANBL0322 | Pediatric patients with recurrent or refractory Neuroblastoma | Open |
updated: 4/22/09
Back to top